Zeinac Pharmaceuticals Private Limited
About Zeinac Pharmaceuticals Private Limited
Data last updated:
Zeinac Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 25 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2017PTC097275. Its GSTIN is 09AABCZ1309B1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Shakir Ali and Rizwan Ali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 28 – 29 Shri Krishna Leela Complex 1st Floor Pilibhit Road, Bareilly, Uttar Pradesh, India – 243001.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.05 Lakh, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹8,786 (net margin 0.7%) and EBITDA of ₹11,875 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 97% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zeinac Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address28 – 29 Shri Krishna Leela Complex 1st Floor Pilibhit Road, Bareilly, Uttar Pradesh, India – 243001
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Zeinac Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zeinac Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zeinac Pharmaceuticals Private Limited, buy the company report.
Financials of Zeinac Pharmaceuticals Private Limited
FY 2025 filings availableZeinac Pharmaceuticals Private Limited reported revenue of ₹12.05 Lakh (up 47% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 97% over five years, including 47% growth in the latest year. EBITDA rose 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,875 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,786 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zeinac Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zeinac Pharmaceuticals Private Limited
Zeinac Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shakir Ali | Director | 25 Sep 2017 | 9 Years 1 Months | Current |
| Rizwan Ali | Director | 25 Sep 2017 | 9 Years 1 Months | Current |
Peer comparison
Zeinac Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Souris Pharmaceuticals Private Limited | ₹12.06 Lakh (FY 2025) | -7.0% | Bangalore, Karnataka, India | |||
| Zeinac Pharmaceuticals Private Limitedthis company | ₹12.05 Lakh (FY 2024) | ₹8,786 | 0.7% | 47.0% | Bareilly, Uttar Pradesh, India | |
| Klyrich Pharmaceuticals Private Limited | ₹11.99 Lakh (FY 2025) | -18.0% | Lucknow, Uttar Pradesh, India | |||
| Sternum Pharmaceuticals Private Limited | ₹11.99 Lakh (FY 2023) | Ayodhya, Uttar Pradesh, India | ||||
| Singulans Pharmaceuticals Private Limited | ₹11.97 Lakh (FY 2024) | 4428.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Zeinac Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zeinac Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zeinac Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zeinac Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCZ1309B1ZQ | Uttar Pradesh | Active | 28 Nov 2018 |
To see the full GST registrations and return filing status of Zeinac Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zeinac Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Abhishek Agarwal ceased to be Director on 15 Sep 2021.
Frequently asked questions
Zeinac Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 25 September 2017 (9+ years old) and is registered under CIN U74999UP2017PTC097275.
Zeinac Pharmaceuticals has 2 current directors:
- Shakir Ali - Director
- Rizwan Ali - Director
The latest financial statements of Zeinac Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Zeinac Pharmaceuticals is 09AABCZ1309B1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Zeinac Pharmaceuticals is U74999UP2017PTC097275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zeinac Pharmaceuticals was incorporated on 25 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Zeinac Pharmaceuticals by revenue are Souris Pharmaceuticals Private Limited, Klyrich Pharmaceuticals Private Limited, Sternum Pharmaceuticals Private Limited, Singulans Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Abhishek Agarwal ceased to be Director on 15 Sep 2021. Rizwan Ali was appointed as Director on 25 Sep 2017. Shakir Ali was appointed as Director on 25 Sep 2017.
The registered office of Zeinac Pharmaceuticals is at 28 – 29 Shri Krishna Leela Complex 1st Floor Pilibhit Road, Bareilly, Uttar Pradesh, India – 243001.
Zeinac Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Zeinac Pharmaceuticals is compliant as of 27 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
